Position in WAT
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$927,473
+$18,886 QoQ
Shares Held
2,473
-18.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#499
of 1,173 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in WAT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $199,150,782 across 8 Diagnostics & Research names. WAT ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
653,183 | $124,418,297 | |
| 2 | LH |
Labcorp Holdings Inc.
|
218,731 | $61,244,680 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
18,789 | $4,261,157 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
5,866 | $2,940,977 | |
| 5 | DGX |
Quest Diagnostics Inc
|
12,820 | $2,717,199 | |
| 6 | QGEN |
Qiagen N.V.
|
56,506 | $2,209,384 | |
| 7 | WAT |
Waters Corp /De/
This page
|
2,473 | $927,473 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
815 | $431,615 |
All Filings in WAT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $927,473 | 2,473 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $908,587 | 3,051 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $438,703 | 1,155 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $346,280 | 1,155 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $403,141 | 1,155 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $401,004 | 1,088 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $402,142 | 1,084 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $391,200 | 1,087 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $314,490 | 1,084 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $361,441 | 1,050 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $345,691 | 1,050 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $287,920 | 1,050 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $281,732 | 1,057 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $415,523 | 1,342 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $428,225 | 1,250 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $336,912 | 1,250 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $413,725 | 1,250 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $325,909 | 1,050 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $409,860 | 1,100 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $393,030 | 1,100 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $380,171 | 1,100 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $298,378 | 1,050 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $259,791 | 1,050 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $205,464 | 1,050 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||